4.8 Article

Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1606791113

关键词

alpha-synuclein; copper; H50Q mutation; inclusions; protein aggregation

资金

  1. European Community [238316]
  2. European Union [H2020-EINFRA-2015-1-675728]
  3. Dorothea Schlozer Programme of the Georg August University Gottingen
  4. Fundacao para a Ciencia e Tecnologia [SFRH/BD/74881/2010, SFRH/BD/80884/2011]
  5. Comissao de Aperfeicoamento de Pessoal de Nival Superior-Science without Borders
  6. CNPq
  7. Deutsche Forschungsgemeinschaft (DFG)
  8. Emmy Noether/DFG grant
  9. Catalan Institution for Research and Advanced Studies-Academia program
  10. DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain
  11. Fundação para a Ciência e a Tecnologia [SFRH/BD/74881/2010, SFRH/BD/80884/2011] Funding Source: FCT

向作者/读者索取更多资源

Synucleinopathies are a group of progressive disorders characterized by the abnormal aggregation and accumulation of alpha-synuclein (aSyn), an abundant neuronal protein that can adopt different conformations and biological properties. Recently, aSyn pathology was shown to spread between neurons in a prion-like manner. Proteins like aSyn that exhibit self-propagating capacity appear to be able to adopt different stable conformational states, known as protein strains, which can be modulated both by environmental and by protein-intrinsic factors. Here, we analyzed these factors and found that the unique combination of the neurodegeneration-related metal copper and the pathological H50Q aSyn mutation induces a significant alteration in the aggregation properties of aSyn. We compared the aggregation of WT and H50Q aSyn with and without copper, and assessed the effects of the resultant protein species when applied to primary neuronal cultures. The presence of copper induces the formation of structurally different and less-damaging aSyn aggregates. Interestingly, these aggregates exhibit a stronger capacity to induce aSyn inclusion formation in recipient cells, which demonstrates that the structural features of aSyn species determine their effect in neuronal cells and supports a lack of correlation between toxicity and inclusion formation. In total, our study provides strong support in favor of the hypothesis that protein aggregation is not a primary cause of cytotoxicity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Predictions of the Poses and Affinity of a Ligand over the Entire Surface of a NEET Protein: The Case of Human MitoNEET

Ke Zuo, Riccardo Capelli, Giulia Rossetti, Rachel Nechushtai, Paolo Carloni

Summary: Human NEET proteins containing iron-sulfur clusters have been identified as potential drug targets for mitochondrial dysfunction-related diseases. However, the lack of understanding of ligand binding to the cytoplasmic domain of NEET protein has hindered rational drug design approaches.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Editorial Material Neurosciences

The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets

Tiago Fleming Outeiro, Omar M. El-Agnaf

NEUROBIOLOGY OF DISEASE (2023)

Article Nanoscience & Nanotechnology

OligoBinders: Bioengineered Soluble Amyloid-like Nanoparticles to Bind and Neutralize SARS-CoV-2

Molood Behbahanipour, Roger Benoit, Susanna Navarro, Salvador Ventura

Summary: A novel nanoparticle has been developed that can neutralize SARS-CoV-2 virus. The nanoparticle is biocompatible and stable, and shows potential for therapeutic and diagnostic applications.

ACS APPLIED MATERIALS & INTERFACES (2023)

Article Chemistry, Medicinal

Drug Design in the Exascale Era: A Perspective from Massively Parallel QM/MM Simulations

Bharath Raghavan, Mirko Paulikat, Katya Ahmad, Lara Callea, Andrea Rizzi, Emiliano Ippoliti, Davide Mandelli, Laura Bonati, Marco De Vivo, Paolo Carloni

Summary: Currently, in silico drug design in the initial stages of drug discovery can benefit from first-principle Quantum Mechanics/Molecular Mechanics (QM/MM) molecular dynamics (MD) simulations in explicit solvent, but many applications are limited by the short time scales that this approach can cover. The development of scalable first principle QM/MM MD interfaces that fully exploit current exascale machines is crucial in overcoming this problem and allowing for the study of ligand binding to protein with first principle accuracy. This study showcases the use of the Multiscale Modeling in Computational Chemistry (MiMiC) QM/MM framework, which demonstrates strong scaling and parallel efficiency of >70% up to >80,000 cores, making it a promising candidate for exascale applications.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Article Chemistry, Medicinal

MiMiCPy: An Efficient Toolkit for MiMiC-Based QM/MM Simulations

Bharath Raghavan, Florian K. Schackert, Andrea Levy, Sophia K. Johnson, Emiliano Ippoliti, Davide Mandelli, Jogvan Magnus Haugaard Olsen, Ursula Rothlisberger, Paolo Carloni

Summary: MiMiC is a flexible and scalable multiscale modeling framework that combines quantum mechanics (QM) and molecular mechanics (MM) codes. The paragraph introduces MiMiCPy, a user-friendly tool written in Python 3 that automates the preparation of MiMiC input files. It also highlights the modular structure of MiMiCPy, allowing for easy extensions to new program formats.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Article Chemistry, Medicinal

Mechanism of Calcium Permeation in a Glutamate Receptor Ion Channel

Florian Karl Schackert, Johann Biedermann, Saeid Abdolvand, Sonja Minniberger, Chen Song, Andrew J. R. Plested, Paolo Carloni, Han Sun

Summary: This study investigates calcium conduction in calcium-permeable AMPAR using Molecular Dynamics (MD) simulations and multiscale Quantum Mechanics/Molecular Mechanics (QM/MM) simulations. The results explain the distinct calcium permeability in different RNA-edited forms of GluA2 and provide unprecedented insights into Ca(2+) permeation mechanisms in AMPARs.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Review Biochemistry & Molecular Biology

Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials

Luca Marsili, Jennifer Sharma, Tiago Fleming Outeiro, Carlo Colosimo

Summary: Stem cell-based therapies (SCT) have potential in treating neurodegenerative disorders, but clinical trials are just starting and results may take several years. SCTs can provide both symptomatic and disease-modifying effects, and may complement molecular therapies in precision medicine.

BIOMEDICINES (2023)

Article Biology

SPEADI: Accelerated Analysis of IDP-Ion Interactions from MD-Trajectories

Emile de Bruyn, Anton Emil Dorn, Olav Zimmermann, Giulia Rossetti

Summary: This study introduces a method called Time-Resolved Radial Distribution Function (TRRDF) to characterize the local environment dynamics around Intrinsically Disordered Proteins (IDPs) that are sensitive to changes in chemical environmental conditions. The authors used their open-source Python package SPEADI to analyze the dynamic distribution of ions around IDPs Alpha-Synuclein (AS) and Humanin (HN) from Molecular Dynamics (MD) simulations, revealing the significant role of ion-residue interactions in the structures and behaviors of IDPs.

BIOLOGY-BASEL (2023)

Article Chemistry, Multidisciplinary

Amyloid Fibrils Formed by Short Prion-Inspired Peptides Are Metalloenzymes

Susanna Navarro, Marta Diaz-Caballero, Francesca Peccati, Lorena Roldan-Martin, Mariona Sodupe, Salvador Ventura

Summary: Enzymes fold into specific 3D protein structures and exhibit high catalytic efficiency and selectivity. Artificial amyloids have been shown to have catalytic activity and advantages over natural enzymes. A recent study found that short peptides can self-assemble into amyloid fibrils with catalytic activity by coordinating and retaining different divalent metal cations. These findings provide new insights into the design of artificial metalloenzymes and support the role of amyloid-like structures in the origin of life.

ACS NANO (2023)

Article Biochemistry & Molecular Biology

Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR

Benjamin Philipp Joseph, Verena Weber, Lisa Knuepfer, Alejandro Giorgetti, Mercedes Alfonso-Prieto, Sybille Krauss, Paolo Carloni, Giulia Rossetti

Summary: In this study, novel HuR inhibitors were identified using a combination of chemoinformatic methods, high-throughput virtual screening, and RNA-protein pulldown assays. The 4-(2-(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)hydrazineyl)benzoate ligand showed dose-dependent inhibition of HuR binding. This novel chemical scaffold provides a new avenue for the design of pharmaceutical agents targeting HuR.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

News Item Biochemistry & Molecular Biology

Chemical targeting of amyloids

Javier Garcia-Pardo, Salvador Ventura

NATURE CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

A3D Model Organism Database (A3D-MODB): a database for proteome aggregation predictions in model organisms

Aleksandra E. Badaczewska-Dawid, Aleksander Kuriata, Carlos Pintado-Grima, Javier Garcia-Pardo, Michal Burdukiewicz, Valentin Iglesias, Sebastian Kmiecik, Salvador Ventura

Summary: Protein aggregation is associated with aging and different pathologies, and is a challenge in the industrial production of biotherapeutics. Previous research in model organisms has provided insights into the biophysical principles of this process and led to the development of computational tools. A3D-MODB is a comprehensive database that allows for the study of protein aggregation in 12 model species and provides additional information for better understanding protein aggregation.

NUCLEIC ACIDS RESEARCH (2023)

Article Chemistry, Multidisciplinary

AI-based identification of therapeutic agents targeting GPCRs: introducing ligand type classifiers and systems biology

Jonas Gossen, Rui Pedro Ribeiro, Dirk Bier, Bernd Neumaier, Paolo Carloni, Alejandro Giorgetti, Giulia Rossetti

Summary: This study presents an approach that combines structural data with a random forest agonist/antagonist classifier and a signal-transduction kinetic model to identify novel chemotype ligands. As a test case, the approach is applied to identify novel antagonists of the human adenosine transmembrane receptor type 2A, a target against Parkinson's disease and cancer.

CHEMICAL SCIENCE (2023)

Article Chemistry, Physical

Metadynamics simulations of ligands binding to protein surfaces: a novel tool for rational drug design

Ke Zuo, Agata Kranjc, Riccardo Capelli, Giulia Rossetti, Rachel Nechushtai, Paolo Carloni

Summary: This study introduces a new drug design approach that combines metadynamics free energy methods and experimental structural information to identify ligand poses on protein surfaces.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2023)

暂无数据